ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Efficacy and safety of tralokinumab plus topical corticosteroids in patients with severe atopic dermatitis and prior history of dupilumab treatment: a post hoc subgroup analysis from ECZTRA 7 trial
SKIN The Journal of Cutaneous Medicine
◽
10.25251/skin.5.supp.60
◽
2021
◽
Vol 5
(6)
◽
pp. s60
Author(s):
Jan Gutermuth
◽
Andrew Pink
◽
Margitta Worm
◽
Lise Soldbro
◽
Thomas Mark
◽
...
Keyword(s):
Atopic Dermatitis
◽
Subgroup Analysis
◽
Prior History
◽
Severe Atopic Dermatitis
◽
Efficacy And Safety
◽
Topical Corticosteroids
◽
History Of
◽
Post Hoc
N/A
Download Full-text
Related Documents
Cited By
References
Dupilumab in Adolescents With Moderate-to-Severe Atopic Dermatitis and a History of Allergic Rhinitis: Subgroup Analysis From a Phase 3 Trial
Journal of Allergy and Clinical Immunology
◽
10.1016/j.jaci.2019.12.267
◽
2020
◽
Vol 145
(2)
◽
pp. AB191
Author(s):
Lawrence Sher
◽
Weily Soong
◽
Paola Mina-Osorio
◽
Randy Prescilla
◽
Zhen Chen
◽
...
Keyword(s):
Allergic Rhinitis
◽
Atopic Dermatitis
◽
Subgroup Analysis
◽
Severe Atopic Dermatitis
◽
Phase 3
◽
History Of
Download Full-text
Efficacy and Safety of Baricitinib Combined With Topical Corticosteroids for Treatment of Moderate to Severe Atopic Dermatitis
JAMA Dermatology
◽
10.1001/jamadermatol.2020.3260
◽
2020
◽
Vol 156
(12)
◽
pp. 1333
◽
Cited By ~ 2
Author(s):
Kristian Reich
◽
Kenji Kabashima
◽
Ketty Peris
◽
Jonathan I. Silverberg
◽
Lawrence F. Eichenfield
◽
...
Keyword(s):
Atopic Dermatitis
◽
Severe Atopic Dermatitis
◽
Efficacy And Safety
◽
Topical Corticosteroids
Download Full-text
Faculty Opinions recommendation of Efficacy and safety of lebrikizumab (an anti-IL-13 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical corticosteroids: A randomized, placebo-controlled phase II trial (TREBLE).
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.732534767.793543516
◽
2018
◽
Author(s):
Hidehisa Saeki
Keyword(s):
Monoclonal Antibody
◽
Atopic Dermatitis
◽
Phase Ii
◽
Phase Ii Trial
◽
Severe Atopic Dermatitis
◽
Efficacy And Safety
◽
Topical Corticosteroids
Download Full-text
621 Dupilumab in adolescents with moderate-to-severe atopic dermatitis and a history of inadequate response, or intolerance to cyclosporine: subgroup analysis from a pivotal 16-week trial
Journal of Investigative Dermatology
◽
10.1016/j.jid.2019.03.697
◽
2019
◽
Vol 139
(5)
◽
pp. S106
Author(s):
A.S. Paller
◽
E.L. Simpson
◽
M. de Bruin-Weller
◽
J. Weisman
◽
B. Lockshin
◽
...
Keyword(s):
Atopic Dermatitis
◽
Subgroup Analysis
◽
Severe Atopic Dermatitis
◽
Inadequate Response
◽
History Of
Download Full-text
Efficacy and safety of dupilumab with concomitant topical corticosteroids in children 6 to 11 years old with severe atopic dermatitis: A randomized, double-blinded, placebo-controlled phase 3 trial
Journal of the American Academy of Dermatology
◽
10.1016/j.jaad.2020.06.054
◽
2020
◽
Vol 83
(5)
◽
pp. 1282-1293
◽
Cited By ~ 10
Author(s):
Amy S. Paller
◽
Elaine C. Siegfried
◽
Diamant Thaçi
◽
Andreas Wollenberg
◽
Michael J. Cork
◽
...
Keyword(s):
Atopic Dermatitis
◽
Severe Atopic Dermatitis
◽
Efficacy And Safety
◽
Phase 3
◽
Topical Corticosteroids
◽
Double Blinded
Download Full-text
Efficacy and Safety of Tralokinumab Plus Concomitant Topical Corticosteroids (TCS) in Adult Patients with Moderate-to-Severe Atopic Dermatitis: Results from the 32-Week, Phase 3 ECZTRA 3 Trial
SKIN The Journal of Cutaneous Medicine
◽
10.25251/skin.4.supp.102
◽
2020
◽
Vol 4
(6)
◽
pp. s102
Author(s):
Stephan Weidinger
◽
Jonathan Silverberg
◽
Darryl Toth
◽
Thomas Bieber
◽
Andrew Alexis
◽
...
Keyword(s):
Atopic Dermatitis
◽
Adult Patients
◽
Severe Atopic Dermatitis
◽
Efficacy And Safety
◽
Phase 3
◽
Topical Corticosteroids
Abstract not available.
Download Full-text
Dupilumab in Adolescents With Moderate-to-Severe Atopic Dermatitis and a History of Allergic Rhinitis: Subgroup Analysis From a Phase 3 Trial (LIBERTY AD ADOL)
SKIN The Journal of Cutaneous Medicine
◽
10.25251/skin.4.supp.50
◽
2020
◽
Vol 4
(5)
◽
pp. s51
Author(s):
Lawrence Sher
◽
Weily Soong
◽
Randy Prescilla
◽
Zhen Chen
◽
Ashish Bansal
Keyword(s):
Allergic Rhinitis
◽
Atopic Dermatitis
◽
Subgroup Analysis
◽
Severe Atopic Dermatitis
◽
Phase 3
◽
History Of
Abstract not available.
Download Full-text
Efficacy and Safety of Tralokinumab with Concomitant Topical Corticosteroids in North American Adults with Moderate-to-Severe Atopic Dermatitis: A Subanalysis of the ECZTRA 3 Trial
SKIN The Journal of Cutaneous Medicine
◽
10.25251/skin.4.supp.97
◽
2020
◽
Vol 4
(6)
◽
pp. s97
Author(s):
Boni E. Elewski
◽
Matthew J. Zirwas
◽
Richard G. Langley
◽
Andrew F. Alexis
◽
Karen A. Veverka
◽
...
Keyword(s):
Atopic Dermatitis
◽
North American
◽
Severe Atopic Dermatitis
◽
Efficacy And Safety
◽
Topical Corticosteroids
Abstract not available.
Download Full-text
Efficacy and safety of lebrikizumab (an anti-IL-13 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical corticosteroids: A randomized, placebo-controlled phase II trial (TREBLE)
Journal of the American Academy of Dermatology
◽
10.1016/j.jaad.2018.01.017
◽
2018
◽
Vol 78
(5)
◽
pp. 863-871.e11
◽
Cited By ~ 123
Author(s):
Eric L. Simpson
◽
Carsten Flohr
◽
Lawrence F. Eichenfield
◽
Thomas Bieber
◽
Howard Sofen
◽
...
Keyword(s):
Monoclonal Antibody
◽
Atopic Dermatitis
◽
Phase Ii
◽
Phase Ii Trial
◽
Severe Atopic Dermatitis
◽
Efficacy And Safety
◽
Topical Corticosteroids
Download Full-text
Evaluation of the Efficacy and Safety of Lebrikizumab in Moderate to Severe Atopic Dermatitis
Case Medical Research
◽
10.31525/ct1-nct04178967
◽
2019
◽
Author(s):
Keyword(s):
Atopic Dermatitis
◽
Severe Atopic Dermatitis
◽
Efficacy And Safety
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close